Koeplinger KA et al
The oral bioavailability is roughly 1%, which is why the oral doses (3 mg, 7 mg, 14 mg daily) appear higher than the injectable doses but deliver similar systemic exposure
The need-to-know this morning More pharma earnings: Merck, Bristol Myers Squibb and Eli Lilly Notable biotech earnings: Alnylam
Lopez readily discussed her sons condition and their struggle to pay for his treatment, but asked that his last name be withheld for privacy due to his schizophrenia
Looks like I have to say goodbye to chocolate
In animal models, imaging studies and clinical trials, including those aimed at studying the effectiveness of GLP-1RAs for the treatment of dementia syndromes, have shown that in patients with insulin resistance and T2DM, as well as dementia, there is an energy deficiency of the brain, and the heterogeneity of changes in energy metabolism depending on dementia syndromes may affect the effectiveness of GLP-1RAs [23]